Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - FR0013467479 - Common Stock

14.325 USD
+0.59 (+4.33%)
Last: 9/10/2025, 1:58:06 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CSTM. CSTM was compared to 155 industry peers in the Metals & Mining industry. There are concerns on the financial health of CSTM while its profitability can be described as average. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
CSTM had a positive operating cash flow in the past year.
Of the past 5 years CSTM 4 years were profitable.
Each year in the past 5 years CSTM had a positive operating cash flow.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CSTM has a better Return On Assets (2.44%) than 65.16% of its industry peers.
Looking at the Return On Equity, with a value of 16.83%, CSTM belongs to the top of the industry, outperforming 89.68% of the companies in the same industry.
The Return On Invested Capital of CSTM (11.15%) is better than 85.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CSTM is below the industry average of 13.00%.
The 3 year average ROIC (8.33%) for CSTM is below the current ROIC(11.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROIC 11.15%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

The Profit Margin of CSTM (0.99%) is better than 61.94% of its industry peers.
CSTM's Profit Margin has declined in the last couple of years.
CSTM has a Operating Margin (3.72%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CSTM has declined.
Looking at the Gross Margin, with a value of 12.18%, CSTM is in line with its industry, outperforming 47.10% of the companies in the same industry.
In the last couple of years the Gross Margin of CSTM has grown nicely.
Industry RankSector Rank
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CSTM is still creating some value.
The number of shares outstanding for CSTM has been reduced compared to 1 year ago.
The number of shares outstanding for CSTM has been increased compared to 5 years ago.
The debt/assets ratio for CSTM is higher compared to a year ago.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.20 indicates that CSTM is not in any danger for bankruptcy at the moment.
CSTM's Altman-Z score of 3.20 is in line compared to the rest of the industry. CSTM outperforms 57.42% of its industry peers.
A Debt/Equity ratio of 2.53 is on the high side and indicates that CSTM has dependencies on debt financing.
CSTM's Debt to Equity ratio of 2.53 is on the low side compared to the rest of the industry. CSTM is outperformed by 90.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Altman-Z 3.2
ROIC/WACC1.3
WACC8.55%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.23 indicates that CSTM should not have too much problems paying its short term obligations.
CSTM has a Current ratio of 1.23. This is in the lower half of the industry: CSTM underperforms 76.13% of its industry peers.
A Quick Ratio of 0.53 indicates that CSTM may have some problems paying its short term obligations.
CSTM's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CSTM is outperformed by 87.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The earnings per share for CSTM have decreased strongly by -73.49% in the last year.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
CSTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 80.43%.
CSTM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%

3.2 Future

CSTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.98% yearly.
CSTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.56% yearly.
EPS Next Y167.79%
EPS Next 2Y101.65%
EPS Next 3Y67.98%
EPS Next 5YN/A
Revenue Next Year16.03%
Revenue Next 2Y10.72%
Revenue Next 3Y13.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.40, the valuation of CSTM can be described as expensive.
Based on the Price/Earnings ratio, CSTM is valued a bit cheaper than 63.23% of the companies in the same industry.
CSTM is valuated expensively when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.57, which indicates a very decent valuation of CSTM.
86.45% of the companies in the same industry are more expensive than CSTM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (22.59), we can say CSTM is valued rather cheaply.
Industry RankSector Rank
PE 49.4
Fwd PE 8.57
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

92.90% of the companies in the same industry are more expensive than CSTM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.93
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CSTM may justify a higher PE ratio.
CSTM's earnings are expected to grow with 67.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)15.13
EPS Next 2Y101.65%
EPS Next 3Y67.98%

0

5. Dividend

5.1 Amount

No dividends for CSTM!.
Industry RankSector Rank
Dividend Yield N/A

CONSTELLIUM SE

NYSE:CSTM (9/10/2025, 1:58:06 PM)

14.325

+0.59 (+4.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners92.96%
Inst Owner Change-0.02%
Ins Owners1.78%
Ins Owner ChangeN/A
Market Cap2.10B
Analysts82.22
Price Target19.38 (35.29%)
Short Float %2.49%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)129.83%
Min EPS beat(2)-17.42%
Max EPS beat(2)277.07%
EPS beat(4)1
Avg EPS beat(4)-188.59%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-110.02%
EPS beat(12)3
Avg EPS beat(12)-76.02%
EPS beat(16)5
Avg EPS beat(16)-28.44%
Revenue beat(2)1
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-5.83%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.56%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)4
Avg Revenue beat(12)-1.8%
Revenue beat(16)8
Avg Revenue beat(16)0.42%
PT rev (1m)0%
PT rev (3m)10.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)6.91%
EPS NY rev (3m)-3.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 49.4
Fwd PE 8.57
P/S 0.16
P/FCF N/A
P/OCF 8.82
P/B 2.7
P/tB 3.29
EV/EBITDA 4.93
EPS(TTM)0.29
EY2.02%
EPS(NY)1.67
Fwd EY11.67%
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)1.62
OCFY11.34%
SpS90.29
BVpS5.31
TBVpS4.36
PEG (NY)0.29
PEG (5Y)15.13
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROCE 14.12%
ROIC 11.15%
ROICexc 11.59%
ROICexgc 12.1%
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Debt/EBITDA 2.49
Cap/Depr 131.4%
Cap/Sales 2.96%
Interest Coverage 6
Cash Conversion 30.1%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.53
Altman-Z 3.2
F-Score7
WACC8.55%
ROIC/WACC1.3
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
EPS Next Y167.79%
EPS Next 2Y101.65%
EPS Next 3Y67.98%
EPS Next 5YN/A
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%
Revenue Next Year16.03%
Revenue Next 2Y10.72%
Revenue Next 3Y13.56%
Revenue Next 5YN/A
EBIT growth 1Y29.69%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year108.99%
EBIT Next 3Y38.47%
EBIT Next 5YN/A
FCF growth 1Y-224.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.65%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%